Invention Grant
US08067599B2 Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors
失效
咪唑并[4,5-B]吡啶和吡咯并[2,3-B]吡啶蛋白激酶抑制剂
![Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors](/docs/US/2011-11-29/US08067599B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors
- Patent Title (中): 咪唑并[4,5-B]吡啶和吡咯并[2,3-B]吡啶蛋白激酶抑制剂
-
Application No.: US12374682Application Date: 2007-09-04
-
Publication No.: US08067599B2Publication Date: 2011-11-29
- Inventor: Konrad Honold , Wolfgang Schaefer , Stefan Scheiblich
- Applicant: Konrad Honold , Wolfgang Schaefer , Stefan Scheiblich
- Applicant Address: US NJ Nutley
- Assignee: Hoffman-La Roche Inc.
- Current Assignee: Hoffman-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Patricia S. Rocha-Tramaloni; David E. Wildman
- Priority: EP06018627 20060906
- International Application: PCT/EP2007/007691 WO 20070904
- International Announcement: WO2008/028617 WO 20080313
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04
![Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors](/abs-image/US/2011/11/29/US08067599B2/abs.jpg.150x150.jpg)
Abstract:
Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
Public/Granted literature
- US20090318428A1 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS Public/Granted day:2009-12-24
Information query
IPC分类:
